Prelude Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-79,142
Closed -$10.4M 1470
2025
Q1
$10.4M Buy
+79,142
New +$9.86M 0.79% 11
2024
Q2
Sell
-4,700
Closed -$325K 1560
2024
Q1
$325K Sell
4,700
-9,700
-67% -$667K 0.02% 853
2023
Q4
$1.03M Buy
14,400
+5,600
+64% +$322K 0.07% 299
2023
Q3
$458K Buy
8,800
+49
+0.6% +$2.85K 0.03% 495
2023
Q2
$554K Buy
8,751
+95
+1% +$5.92K 0.04% 429
2023
Q1
$469K Buy
8,656
+26
+0.3% +$1.26K 0.03% 486
2022
Q4
$457K Sell
8,630
-587
-6% -$29.4K 0.02% 604
2022
Q3
$429K Sell
9,217
-1,907
-17% -$99.6K 0.02% 712
2022
Q2
$635K Buy
11,124
+1,117
+11% +$63.3K 0.02% 690
2022
Q1
$612K Sell
10,007
-191
-2% -$9.92K 0.02% 764
2021
Q4
$534K Sell
10,198
-3,802
-27% -$160K 0.01% 964
2021
Q3
$522K Buy
14,000
+3,000
+27% +$104K 0.01% 871
2021
Q2
$449K Buy
+11,000
New +$407K 0.01% 1011
2019
Q2
Sell
-5,318
Closed -$68.2K 2218
2019
Q1
$65K Buy
5,318
+4,889
+1,140% +$62.5K ﹤0.01% 1062
2018
Q4
$5K Sell
429
-18,851
-98% -$304K ﹤0.01% 1632
2018
Q3
$418K Buy
19,280
+181
+0.9% +$3.79K 0.02% 576
2018
Q2
$337K Buy
19,099
+454
+2% +$9.22K 0.02% 641
2018
Q1
$392K Buy
18,645
+17,470
+1,487% +$340K 0.03% 504
2017
Q4
$17K Sell
1,175
-587
-33% -$9.06K ﹤0.01% 1160
2017
Q3
$28K Sell
1,762
-2,953
-63% -$43.3K ﹤0.01% 1249
2017
Q2
$59K Sell
4,715
-4,485
-49% -$52K 0.01% 955
2017
Q1
$150K Buy
+9,200
New +$133K 0.01% 660
2016
Q4
Sell
-28,136
Closed -$429K 1827
2016
Q3
$429K Buy
28,136
+21,567
+328% +$872K 0.05% 342
2016
Q2
$255K Sell
6,569
-1,070
-14% -$38.4K 0.04% 427
2016
Q1
$212K Buy
+7,639
New +$255K 0.03% 534

Other funds holding ITCI